Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation

Tetrathiomolybdate Partially Alleviates Erectile Dysfunction of Type 1 Diabetic Rats Through Affecting Ceruloplasmin/eNOS and Inhibiting Corporal Fibrosis and Systemic Inflammation

Introduction: Patients with erectile dysfunction induced by diabetes mellitus (DMED) show a poor effect rate for oral phosphodiesterase type 5 inhibitors (PDE5is). Therefore, the new therapeutic strategy is necessary in patients with DMED. Aim: To investigate whether Tetrathiomolybdate (TM) suppleme...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yinghao Yin, MS, Jingxuan Peng, MS, Jun Zhou, MS, Hanfei Chen, MS, Dongyi Peng, PhD, Dongjie Li, PhD, Yu Gan, PhD, Guangming Yin, PhD, Yuxin Tang, PhD
Format: article
Langue:EN
Publié: Elsevier 2022
Sujets:
Tetrathiomolybdate
Diabetes Mellitus
Erectile Dysfunction
Ceruloplasmin
eNOS
Medicine
R
Other systems of medicine
RZ201-999
Accès en ligne:https://doaj.org/article/288fc032c5c945c9aee31c19a0d4e9af
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/288fc032c5c945c9aee31c19a0d4e9af

Documents similaires